Exact Mass: 659.2439
Exact Mass Matches: 659.2439
Found 68 metabolites which its exact mass value is equals to given mass value 659.2439
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Neocarzinostatin chromophore
D000970 - Antineoplastic Agents D004791 - Enzyme Inhibitors
Pyridin-2-ylmethyl N-[(2S)-1-[[(2S,4S,5S)-4-hydroxy-1,6-diphenyl-5-(1,3-thiazol-5-ylmethoxycarbonylamino)hexan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamate
Carminomycin II
D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D004791 - Enzyme Inhibitors
Neocarzinostatin chromophore
Carminomycin II
D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D004791 - Enzyme Inhibitors
alpha-L-Rha-(1-2)-alpha-L-Rha-(1-3)-alpha-L-Rha-(1-3)-beta-D-GlcNAc|alphaLRha(1-2)alphaLRha(1-3)alphaLRha(1-3)betaDGlcNac
2-((4R)-4-((3R,5S,7S,8R,9S,10S,13R,17R)-10,13-dimethyl-3,7-bis(sulfooxy)hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid
2-((4R)-4-((3R,5S,7R,9S,10S,13R,14S,17R)-10,13-dimethyl-3,7-bis(sulfooxy)hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid
2-((4R)-4-((3R,5R,9S,10S,12S,13R,14S,17R)-10,13-dimethyl-3,12-bis(sulfooxy)hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid
Glu Trp Tyr Tyr
Glu Tyr Trp Tyr
Glu Tyr Tyr Trp
Trp Glu Tyr Tyr
Trp Tyr Glu Tyr
Trp Tyr Tyr Glu
Tyr Glu Trp Tyr
Tyr Glu Tyr Trp
Tyr Trp Glu Tyr
Tyr Trp Tyr Glu
Tyr Tyr Glu Trp
Tyr Tyr Trp Glu
hydrotris(3-anisylpyrazol-1-yl)borate potassium salt
Fiboflapon sodium
C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent
Dobutamine lactobionate
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent D020011 - Protective Agents > D002316 - Cardiotonic Agents D002317 - Cardiovascular Agents
Valemetostat tosylate
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C156804 - EZH2 Inhibitor
1,3-DI(N-Propyloxy-A-mannopyranosyl)-carbomyl 5-methyazido-benzene
beta-L-arabinofuranosyl-(1->2)-beta-L-arabinofuranosyl-(1->2)-beta-L-arabinofuranosyl-(1->2)-beta-L-arabinofuranosyl-hydroxyproline
(4S)-4-[(2S,3R,4S,5S)-3-[(2R,3R,4S,5S)-3-[(2R,3R,4S,5S)-3-[(2R,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxypyrrolidine-2-carboxylic acid
[(9E)-11-[4,5-dihydroxy-6-methyl-3-(methylamino)oxan-2-yl]oxy-4-(2-oxo-1,3-dioxolan-4-yl)-5-oxatricyclo[8.3.0.04,6]trideca-1(13),9-dien-2,7-diyn-12-yl] 2-hydroxy-7-methoxy-5-methylnaphthalene-1-carboxylate
alpha-L-Rhap-(1->3)-beta-D-GlcpNAc-(1->2)-alpha-L-Rhap-(1->2)-alpha-L-Rhap
6-deoxy-alpha-L-galactopyranosyl-(1->2)-6-deoxy-alpha-L-galactopyranosyl-(1->2)-6-deoxy-alpha-L-galactopyranosyl-(1->3)-2-(acetylamino)-2-deoxy-beta-D-glucopyranose
6-{[alpha-D-galactosyl-(1->3)-alpha-D-galactosyl-(1->4)-N-acetyl-D-glucosaminyl]oxy}hexanoic acid
alpha-L-Rhap-(1->2)-[beta-D-GlcpNAc-(1->3)]-alpha-L-Rhap-(1->3)-alpha-L-Rhap
2-((4R)-4-((3R,5S,7S,8R,9S,10S,13R,17R)-10,13-dimethyl-3,7-bis(sulfooxy)hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid
2-((4R)-4-((3R,5R,9S,10S,12S,13R,14S,17R)-10,13-dimethyl-3,12-bis(sulfooxy)hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid
2-((4R)-4-((3R,5S,7R,9S,10S,13R,14S,17R)-10,13-dimethyl-3,7-bis(sulfooxy)hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid
4,13-bis(acetyloxy)-9-(benzoyloxy)-3,6,6,10,14-pentamethyl-2-oxo-16-oxatetracyclo[10.3.1.0¹,¹².0⁵,⁷]hexadec-10-en-8-yl pyridine-3-carboxylate
2-[(3-{[2,3-dihydroxy-5-(hydroxymethyl)-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclohexyl]amino}-4,5,6-trihydroxycyclohex-1-en-1-yl)methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
3,12-diacetyl-7-benzoyl-8-nicotinoylingol
{"Ingredient_id": "HBIN006918","Ingredient_name": "3,12-diacetyl-7-benzoyl-8-nicotinoylingol","Alias": "NA","Ingredient_formula": "C37H41NO10","Ingredient_Smile": "CC1CC23C(=O)C(C(C4C(C4(C)C)C(C(C(=CC2(C1OC(=O)C)O3)C)OC(=O)C5=CC=CC=C5)OC(=O)C6=CN=CC=C6)OC(=O)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5325","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}